loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Flunixin Meglumine, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Flunixin Meglumine

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    DIGITAL CONTENT

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    2D Structure
    1. Also known as: 42461-84-7, Flunixin meglumin, Banamine, Sch 14714 meglumine, Flumeglumine, Flunixin-s
    Molecular Formula
    C21H28F3N3O7
    Molecular Weight
    491.5  g/mol
    InChI Key
    MGCCHNLNRBULBU-WZTVWXICSA-N
    FDA UNII
    8Y3JK0JW3U
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid
    2.1.2 InChI
    InChI=1S/C14H11F3N2O2.C7H17NO5/c1-8-10(14(15,16)17)5-2-6-11(8)19-12-9(13(20)21)4-3-7-18-12;1-8-2-4(10)6(12)7(13)5(11)3-9/h2-7H,1H3,(H,18,19)(H,20,21);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1
    2.1.3 InChI Key
    MGCCHNLNRBULBU-WZTVWXICSA-N
    2.1.4 Canonical SMILES
    CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.CNCC(C(C(C(CO)O)O)O)O
    2.1.5 Isomeric SMILES
    CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
    2.2 Other Identifiers
    2.2.1 UNII
    8Y3JK0JW3U
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Banamine

    2. Finadyne

    3. Sch 14714 Meglumine

    2.3.2 Depositor-Supplied Synonyms

    1. 42461-84-7

    2. Flunixin Meglumin

    3. Banamine

    4. Sch 14714 Meglumine

    5. Flumeglumine

    6. Flunixin-s

    7. Flunixin N-methylglucanine

    8. Flunixin (meglumine)

    9. Flunixin Meglumine Salt

    10. Sch-14714 Meglumine

    11. Nsc-759583

    12. 8y3jk0jw3u

    13. Finadyne

    14. Chebi:76144

    15. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)nicotinate

    16. 1-deoxy-1-(methylamino)-d-glucitol 2-(2-methyl-3-(perfluoromethyl)anilino)nicotinate

    17. 3-pyridinecarboxylic Acid, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-, Compd. With 1-deoxy-1-(methylamino)-d-glucitol (1:1)

    18. Banamine (veterinary)

    19. Flunixin Meglumine [usan]

    20. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic Acid

    21. Smr000875279

    22. Sr-05000001901

    23. Einecs 255-836-0

    24. Unii-8y3jk0jw3u

    25. Flunixin Meglumine [usan:usp]

    26. Flunixin Meglumine (usp)

    27. Banamine [vetarynary] (tn)

    28. Schembl43691

    29. Bspbio_002558

    30. 2-(alpha(sup 3),alpha(sup 3),alpha(sup 3)-trifluoro-2,3-xylidino)nicotinic Acid Compound With 1-deoxy-1-(methylamino)-d-glucitol (1:1)

    31. Mls001333159

    32. Mls002153985

    33. Spectrum1505113

    34. Chembl1733447

    35. Hms2093i10

    36. Hms2234k05

    37. Hms3884j07

    38. Pharmakon1600-01505113

    39. Flunixin Meglumine [mart.]

    40. Flunixin Meglumine [usp-rs]

    41. Hy-b0386

    42. Flunixin Meglumine Salt [mi]

    43. Mfcd01725419

    44. Nsc759583

    45. S2108

    46. Flunixin Meglumine, >=98% (hplc)

    47. Akos015895954

    48. Ac-6012

    49. Ccg-213338

    50. Flunixin Meglumine [green Book]

    51. Ks-5126

    52. Nsc 759583

    53. Ncgc00180889-01

    54. 2-((2-methyl-3-(trifluoromethyl)-phenyl)amino)-3-pyridinecarboxylic Acid With Meglumine Compounded

    55. D-glucitol, 1-deoxy-1-(methylamino)-, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxylate (salt)

    56. Flunixin Meglumine [usp Monograph]

    57. Sw196448-3

    58. Flunixin Meglumine 100 Microg/ml In Methanol

    59. D04216

    60. H10204

    61. Ab00920714_05

    62. Ab00920714_06

    63. 461f847

    64. Flunixin Meglumine 100 Microg/ml In Acetonitrile

    65. Q-201124

    66. Sr-05000001901-1

    67. Sr-05000001901-3

    68. Q27145782

    69. Flunixin Meglumine, European Pharmacopoeia (ep) Reference Standard

    70. Flunixin Meglumine, United States Pharmacopeia (usp) Reference Standard

    71. Flunixin Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material

    72. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-(2-methyl-3-(trifluoromethyl)phenylamino)nicotinate

    73. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentaol2-((2-methyl-3-(trifluoromethyl)phenyl)amino)nicotinate

    74. 1-deoxy-1-(methylazaniumyl)-d-glucitol 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinate

    75. 2-(.alpha.(sup 3),.alpha.(sup 3),.alpha.(sup 3)-trifluoro-2,3-xylidino)nicotinic Acid Compound With 1-deoxy-1-(methylamino)-d-glucitol (1:1)

    76. 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinic Acid--1-deoxy-1-(methylamino)-d-glucitol (1/1)

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 491.5 g/mol
    Molecular Formula C21H28F3N3O7
    Hydrogen Bond Donor Count8
    Hydrogen Bond Acceptor Count13
    Rotatable Bond Count9
    Exact Mass491.18793473 g/mol
    Monoisotopic Mass491.18793473 g/mol
    Topological Polar Surface Area175 Ų
    Heavy Atom Count34
    Formal Charge0
    Complexity510
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Inflammatory Agents, Non-Steroidal

    Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)

    Antipyretics

    Drugs that are used to reduce body temperature in fever. (See all compounds classified as Antipyretics.)

    Post Enquiry
    POST ENQUIRY